Author(s): Rauh VA, Garfinkel R, Perera FP, Andrews HF, Hoepner L, et al.
OBJECTIVE. The purpose of this study was to investigate the impact of prenatal exposure to chlorpyrifos on 3-year neurodevelopment and behavior in a sample of inner-city minority children.
METHODS. As part of an ongoing prospective cohort study in an inner-city minority population, neurotoxicant effects of prenatal exposure to chlorpyrifos were evaluated in 254 children through the first 3 years of life. This report examined cognitive and motor development at 12, 24, and 36 months (measured with the Bayley Scales of Infant Development II) and child behavior at 36 months (measured with the Child Behavior Checklist) as a function of chlorpyrifos levels in umbilical cord plasma.
RESULTS. Highly exposed children (chlorpyrifos levels of >6.17 pg/g plasma) scored, on average, 6.5 points lower on the Bayley Psychomotor Development Index and 3.3 points lower on the Bayley Mental Development Index at 3 years of age compared with those with lower levels of exposure. Children exposed to higher, compared with lower, chlorpyrifos levels were also significantly more likely to experience Psychomotor Development Index and Mental Development Index delays, attention problems, attention-deficit/hyperactivity disorder problems, and pervasive developmental disorder problems at 3 years of age.
CONCLUSIONS. The adjusted mean 36-month Psychomotor Development Index and Mental Development Index scores of the highly and lower exposed groups differed by only 7.1 and 3.0 points, respectively, but the proportion of delayed children in the high-exposure group, compared with the low-exposure group, was 5 times greater for the Psychomotor Development Index and 2.4 times greater for the Mental Development Index, increasing the number of children possibly needing early intervention services.
Referred From: https://publications.aap.org/pediatrics/article/118/6/e1845/69738/Impact-of-Prenatal-Chlorpyrifos-Exposure-on
Author(s): Colborn T
Author(s): Herbert MR
Author(s): Grandjean P, Landrigan PJ
Author(s): Grandjean P, Landrigan PJ
Author(s): Makris SL, Raffaele K, Allen S, Bowers WJ, Hasset U
Author(s): Middaugh LD, Dow-Edwards D, Li AA
Author(s): Cooper RL, Lamb JC, Barlow SM
Author(s): Doe JE, Boobis AR, Blacker A, Dellarco V, Doerrer NG, et al.
Author(s): Couillard-Despres S, Quehl E, Altendorfer K, Bentley K, Brady AM, et al.
Author(s): Hill EJ, Woehrling EK, Prince M, Coleman MD
Author(s): Hou Z, Zhang J, Schwartz MP, Stewart R, Page CD, et al.
Author(s): Laurenza I, Pallocca G, Mennecozzi M, Scelfo B, Pamies D, et al.
Author(s): Menzner AK, AbolpourMofrad S, Friedrich O, Gilbert DF
Author(s): Pallocca G, Fabbri M, Sacco MG, Gribaldo L, Pamies D, et al.
Author(s): Haile Y, Fu W, Shi B, Westaway D, Baker G, et al.
Author(s): Andrews PW
Author(s): Coyne L, Shan M, Przyborski SA, Hirakawa R, Halliwell RF
Author(s): Kuenzel K, Friedrich O, Gilbert DF
Author(s): Pleasure SJ, Lee VM
Author(s): Pleasure SJ, Page C, Lee VM
Author(s): Stewart R, Coyne L, Lako M, Halliwell RF, Przyborski SA
Author(s): Hsu TC, Liu KK, Chang HC, Hwang E, Chao JI
Author(s): Megiorni F, Mora B, Indovina P, Mazzilli MC
Author(s): Paquet-Durand F, Tan S, Bicker G
Author(s): Podrygajlo G, Tegenge MA, Gierse A
Author(s): Yao ZX, Han Z, Xu J, Greeson J, Lecanu L, et al.
Author(s): AbolpourMofrad S, Kuenzel K, Friedrich O, Gilbert DF